AI empowers Precision Medicine; The EU AI Act and Its Impact on the Tech Sector; Data Centers in Orbit; New Chip for AI Unveiled and more...

An insider’s update on Deep Tech: Your dose of tech innovations, startups, exponential industries, policies, and market moves to stay ahead and capitalize on it.

Welcome to The Scenarionist’s Sunday Brief, where we discuss 5 crucial facts from the week shaping the Global Deep Tech landscape at the intersection of technology, policy, and markets.

Get practical insights from cutting-edge tech innovations to the most significant startups and capital moves to stay ahead, stay competitive, and seize new market opportunities.

---

In today's briefing, we delve into groundbreaking advancements spanning the realms of healthcare, technology regulation, space exploration, and semiconductor innovation. Our journey begins with the transformative potential of AI in precision medicine, as exemplified by Zephyr AI's recent funding milestone. From there, we explore the European Union's pioneering AI Act and its profound implications for the tech sector. Transitioning to the cosmos, we uncover the emergence of data centers in orbit, spearheaded by Lumen Orbit's innovative approach. Lastly, we unveil the unveiling of Cerebras Systems' Wafer-Scale Engine 3, a game-changing chip promising unparalleled performance in AI processing. Join us as we unravel the frontiers of innovation shaping our future.

---

📣 Sponsor

The Scenarionist

to actively support open-source education in scientific entrepreneurship and gain visibility among founders, VCs, and experts in the Deep Tech industry. ➡️ Reach out to us at info@thescenarionist.org

---

Empowering Precision Medicine with AI: Zephyr AI Raises $111 Million

In the health and technology sector, the announcement of Zephyr AI's recent $111 million Series A funding round marks a pivotal moment in the democratization of precision medicine through the development of explainable Artificial Intelligence (AI) algorithms.

Credit: Zephyr AI.  “Reconstructing gene expression from clinical and genetic panel data for predictions of tumor microenvironment features and response to immune checkpoint inhibitor therapy.” Society For Immunotherapy of Cancer (SITC). 38th Annual Meeting & Pre-Conference Programs. Journal for Immunotherapy of Cancer (JITC) preprint. Abstract #1296.